Validation of Surrogate Endpoints in Multiple Randomized Clinical Trials with Discrete Outcomes
From MaRDI portal
Publication:5121917
DOI10.1002/bimj.200290004zbMath1441.62472OpenAlexW1986604842WikidataQ59901761 ScholiaQ59901761MaRDI QIDQ5121917
Marc Buyse, Tomasz Burzykowski, Helena Geys, Geert Molenberghs, Didier Renard
Publication date: 22 September 2020
Published in: Biometrical Journal (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1002/bimj.200290004
Related Items (4)
Center-within-trial versus trial-level evaluation of surrogate endpoints ⋮ Testing for Heterogeneity in the Utility of a Surrogate Marker ⋮ A pairwise likelihood approach to estimation in multilevel probit models ⋮ The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials
This page was built for publication: Validation of Surrogate Endpoints in Multiple Randomized Clinical Trials with Discrete Outcomes